Clinical Trial

A Study of MHB036C for Advanced Solid Tumor

Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated November 19, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
Phase I/II, dose escalation and dose expansion study to evaluate the efficacy and safety of MHB036C in advanced malignant tumors.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-04-17; most recent amendment 2025-11-16.
Status change: Recruiting → Active, Not Recruiting 2025-11-16
Trial Details
NCT Number NCT06373406
Lead Sponsor Minghui Pharmaceutical (Hangzhou) Ltd
Conditions Advanced Solid Tumor
Enrollment 200 participants
Start Date 2023-05-26
Primary Completion 2025-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-11-19